202 related articles for article (PubMed ID: 30763392)
41. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
Zhu X; Ying J; Wang F; Wang J; Yang H
Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
[TBL] [Abstract][Full Text] [Related]
42. Breast Cancer Molecular Subtypes Defined by ER/PR and HER2 Status: Association with Clinicopathologic Parameters in Ivorian Patients.
Effi AB; Aman NA; Koui BS; Koffi KD; Traore ZC; Kouyate M
Asian Pac J Cancer Prev; 2016; 17(4):1973-8. PubMed ID: 27221883
[TBL] [Abstract][Full Text] [Related]
43. Raman Spectroscopy for Rapid Evaluation of Surgical Margins during Breast Cancer Lumpectomy.
Zúñiga WC; Jones V; Anderson SM; Echevarria A; Miller NL; Stashko C; Schmolze D; Cha PD; Kothari R; Fong Y; Storrie-Lombardi MC
Sci Rep; 2019 Oct; 9(1):14639. PubMed ID: 31601985
[TBL] [Abstract][Full Text] [Related]
44. A comparative analysis of different biofluids towards ovarian cancer diagnosis using Raman microspectroscopy.
Giamougiannis P; Morais CLM; Grabowska R; Ashton KM; Wood NJ; Martin-Hirsch PL; Martin FL
Anal Bioanal Chem; 2021 Jan; 413(3):911-922. PubMed ID: 33242117
[TBL] [Abstract][Full Text] [Related]
45. Different Phases of Breast Cancer Cells: Raman Study of Immortalized, Transformed, and Invasive Cells.
Chaturvedi D; Balaji SA; Bn VK; Ariese F; Umapathy S; Rangarajan A
Biosensors (Basel); 2016 Nov; 6(4):. PubMed ID: 27916791
[TBL] [Abstract][Full Text] [Related]
46. Discrimination of non-melanoma skin lesions from non-tumor human skin tissues in vivo using Raman spectroscopy and multivariate statistics.
Silveira FL; Pacheco MT; Bodanese B; Pasqualucci CA; Zângaro RA; Silveira L
Lasers Surg Med; 2015 Jan; 47(1):6-16. PubMed ID: 25583686
[TBL] [Abstract][Full Text] [Related]
47. Diagnosing breast cancer by using Raman spectroscopy.
Haka AS; Shafer-Peltier KE; Fitzmaurice M; Crowe J; Dasari RR; Feld MS
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12371-6. PubMed ID: 16116095
[TBL] [Abstract][Full Text] [Related]
48. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G
Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283
[TBL] [Abstract][Full Text] [Related]
49. Expression of PC-cell-derived growth factor in benign and malignant human breast epithelium.
Serrero G; Ioffe OB
Hum Pathol; 2003 Nov; 34(11):1148-54. PubMed ID: 14652816
[TBL] [Abstract][Full Text] [Related]
50. Breast cancer or surrounding normal tissue? A successful discrimination by FTIR or Raman microspectroscopy.
Mamede AP; Santos IP; Batista de Carvalho ALM; Figueiredo P; Silva MC; Marques MPM; Batista de Carvalho LAE
Analyst; 2022 Oct; 147(21):4919-4932. PubMed ID: 36190368
[TBL] [Abstract][Full Text] [Related]
51. Discrimination of normal, benign, and malignant breast tissues by Raman spectroscopy.
Chowdary MV; Kumar KK; Kurien J; Mathew S; Krishna CM
Biopolymers; 2006 Dec; 83(5):556-69. PubMed ID: 16897764
[TBL] [Abstract][Full Text] [Related]
52. Raman microspectroscopy based TNM staging and grading of breast cancer.
Zhang B; Zhang Z; Gao B; Zhang F; Tian L; Zeng H; Wang S
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121937. PubMed ID: 36201869
[TBL] [Abstract][Full Text] [Related]
53. In vivo margin assessment during partial mastectomy breast surgery using raman spectroscopy.
Haka AS; Volynskaya Z; Gardecki JA; Nazemi J; Lyons J; Hicks D; Fitzmaurice M; Dasari RR; Crowe JP; Feld MS
Cancer Res; 2006 Mar; 66(6):3317-22. PubMed ID: 16540686
[TBL] [Abstract][Full Text] [Related]
54. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
[TBL] [Abstract][Full Text] [Related]
55. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
Asogan AB; Hong GS; Arni Prabhakaran SK
Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
[TBL] [Abstract][Full Text] [Related]
56. Expression of DNA methylation marker of paired-like homeodomain transcription factor 2 and growth receptors in invasive ductal carcinoma of the breast.
Wan Abdul Rahman WF; Fauzi MH; Jaafar H
Asian Pac J Cancer Prev; 2014; 15(19):8441-5. PubMed ID: 25339043
[TBL] [Abstract][Full Text] [Related]
57. [Application of support vector machine-recursive feature elimination algorithm in Raman spectroscopy for differential diagnosis of benign and malignant breast diseases].
Zhang H; Fu T; Zhang Z; Fan Z; Zheng C; Han B
Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):582-6. PubMed ID: 25430023
[TBL] [Abstract][Full Text] [Related]
58. Automated image morphometry of lobular breast carcinoma.
Rajesh L; Dey P; Joshi K
Anal Quant Cytol Histol; 2002 Apr; 24(2):81-4. PubMed ID: 12026054
[TBL] [Abstract][Full Text] [Related]
59. Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor-alpha and Ki-67 expression.
Shaaban AM; Sloane JP; West CR; Foster CS
Am J Pathol; 2002 Feb; 160(2):597-604. PubMed ID: 11839580
[TBL] [Abstract][Full Text] [Related]
60. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
